These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16950335)

  • 1. A call for transparency at the Global Fund.
    Lancet; 2006 Sep; 368(9538):815. PubMed ID: 16950335
    [No Abstract]   [Full Text] [Related]  

  • 2. Towards a global fund for the health MDGs?
    Epstein H
    Lancet; 2009 Jun; 373(9681):2110-1. PubMed ID: 19541033
    [No Abstract]   [Full Text] [Related]  

  • 3. Towards a global fund for the health MDGs?
    Bermejo A
    Lancet; 2009 Jun; 373(9681):2110. PubMed ID: 19541034
    [No Abstract]   [Full Text] [Related]  

  • 4. Towards a global fund for the health MDGs?
    Cometto G; Ooms G; Starrs A; Zeitz P
    Lancet; 2009 Oct; 374(9696):1146. PubMed ID: 19801093
    [No Abstract]   [Full Text] [Related]  

  • 5. Peter Sands appointed head of the Global fund.
    Zarocostas J
    Lancet; 2017 Nov; 390(10110):2338. PubMed ID: 29185428
    [No Abstract]   [Full Text] [Related]  

  • 6. A global fund for the health MDGs?
    Cometto G; Ooms G; Starrs A; Zeitz P
    Lancet; 2009 May; 373(9674):1500-2. PubMed ID: 19410697
    [No Abstract]   [Full Text] [Related]  

  • 7. Corporate Champions: doing good more effectively.
    Buse K; Samuels F; Pearson M
    Lancet; 2008 Mar; 371(9617):986. PubMed ID: 18358925
    [No Abstract]   [Full Text] [Related]  

  • 8. France and Japan increase support for Global Fund; a new leader is appointed.
    Watson R
    BMJ; 2012 Mar; 344():e2315. PubMed ID: 22451480
    [No Abstract]   [Full Text] [Related]  

  • 9. Misfinancing global health: a case for transparency in disbursements and decision making.
    Sridhar D; Batniji R
    Lancet; 2008 Sep; 372(9644):1185-91. PubMed ID: 18926279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ebola: towards an International Health Systems Fund.
    Gostin LO
    Lancet; 2014 Oct; 384(9951):e49-51. PubMed ID: 25201591
    [No Abstract]   [Full Text] [Related]  

  • 11. What can be learned from data for financing of global health?
    Heller PS
    Lancet; 2009 Jun; 373(9681):2087-8. PubMed ID: 19541023
    [No Abstract]   [Full Text] [Related]  

  • 12. Global Fund suspends payments to Ukraine.
    Parfitt T
    Lancet; 2004 Feb; 363(9408):540. PubMed ID: 14976972
    [No Abstract]   [Full Text] [Related]  

  • 13. Richard Feachem's legacy to the Global Fund.
    Lancet; 2006 Mar; 367(9515):960. PubMed ID: 16564340
    [No Abstract]   [Full Text] [Related]  

  • 14. Will a global fund for cancer be the answer?
    Stefan C
    Nat Rev Clin Oncol; 2018 Apr; 15(4):195-196. PubMed ID: 29335653
    [No Abstract]   [Full Text] [Related]  

  • 15. Who runs global health?
    Lancet; 2009 Jun; 373(9681):2083. PubMed ID: 19541019
    [No Abstract]   [Full Text] [Related]  

  • 16. A new institute for global health evaluations.
    Lancet; 2007 Jun; 369(9577):1902. PubMed ID: 17560426
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors influencing performance of Global Fund-supported tuberculosis grants.
    Katz I; Aziz MA; Olszak-Olszewski M; Komatsu R; Low-Beer D; Atun R
    Int J Tuberc Lung Dis; 2010 Sep; 14(9):1097-103. PubMed ID: 20819253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-communicable diseases and the Paris Declaration.
    Nugent RA; Yach D; Feigl AB
    Lancet; 2009 Sep; 374(9692):784-5. PubMed ID: 19733778
    [No Abstract]   [Full Text] [Related]  

  • 19. World Bank and the Global Financing Facility.
    Fernandes G; Sridhar D
    BMJ; 2017 Aug; 358():j3395. PubMed ID: 28860141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost is killing patients: subsidising effective antimalarials.
    Talisuna A; Grewal P; Rwakimari JB; Mukasa S; Jagoe G; Banerji J
    Lancet; 2009 Oct; 374(9697):1224-6. PubMed ID: 19819377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.